NeOnc Technologies Holdings, Inc Common Stock
Price & Volume
Stats
See moreOpen | $10.76 |
Previous Close | $10.61 |
Day Range | $10.76-$12.15 |
52W Range | $3.20-$25 |
Market Cap | $90.7M |
Shares Short | 123,388 |
Financials
See moreRevenue (12 Mos) | $79,990 |
Revenue Growth (YoY) | -7% |
Gross Profit (12 Mos) | $79,990 |
Diluted EPS | -$2.47 |
News
See moreYahoo Finance • 8 days ago
Blue Gold Appoints Quazar’s Sameer Salgar to Advisory Board to Establish UAE Ties and Guide Digital Gold Strategy
Yahoo Finance • 8 days ago
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
Yahoo Finance • 24 days ago
NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
Yahoo Finance • 30 days ago
NeOnc Technologies Holdings GAAP EPS of $0.30
About
CEO | Dr. Thomas C. Chen M.D., Ph.D. |
CFO | Mr. Keithly A. Garnett |
Address | 23975 Park Sorrento, Calabasas, CA, United States, 91302 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
